Literature DB >> 8570537

Hydroxypropyl-beta-cyclodextrin increases the aqueous solubility and stability of pilocarpine prodrugs.

P Jarho1, A Urtti, T Järvinen.   

Abstract

PURPOSE: The effects of 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD) on the aqueous solubility and stability of two lipophilic bispilocarpine prodrugs were investigated at pH 7.4.
METHODS: The solubility of prodrugs was studied by phase-solubility method (0-72.5 mM HP-beta-CD). The stability of one of the prodrugs was investigated as a function of temperature (40 degrees C-70 degrees C) and HP-beta-CD concentration (0-72.5 mM). The apparent rate constants (k1, k2) for degradation of prodrug in 1:1 and 1:2 inclusion complexes and apparent stability constants (K1:1, K1:2) were calculated by the curve-fitting method.
RESULTS: The phase-solubility diagrams were classified as Ap-type and the apparent stability constants (K1:1, K1:2) for 1:1- and 1:2-inclusion complexes were calculated to be 143-815 M-1 and 29-825 M-1, respectively. The stability of prodrug increased as a function of HP-beta-CD concentration over the studied temperature range. The shelf-life (t90%, calculated by the Arrhenius equation) of the prodrug in 72.5 mM HP-beta-CD solution increased 5.1-fold and 6.1-fold at 25 degrees C and 4 degrees C, respectively.
CONCLUSIONS: The solubility of the prodrugs was shown to increase markedly in phase-solubility studies. The degradation rate of prodrug in stability studies was shown to be slower in the 1:2-complex than in the 1:1-complex and the relative amounts of complex species were found to be dependent on CD concentration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570537     DOI: 10.1023/a:1016290127371

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Pilocarpine levels in the eyes of rabbits following topical application.

Authors:  R Lazare; M Horlington
Journal:  Exp Eye Res       Date:  1975-09       Impact factor: 3.467

2.  New water-soluble pilocarpine derivatives with enhanced and sustained muscarinic activity.

Authors:  P Druzgala; D Winwood; M Drewniak-Deyrup; S Smith; N Bodor; J J Kaminski
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

3.  Beta-cyclodextrins enhance bioavailability of pilocarpine.

Authors:  K A Freedman; J W Klein; C E Crosson
Journal:  Curr Eye Res       Date:  1993-07       Impact factor: 2.424

4.  Effect of 2-hydroxypropyl-beta-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate.

Authors:  A Usayapant; A H Karara; M M Narurkar
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

5.  Improved corneal pilocarpine permeability with O,O'-(1,4-xylylene) bispilocarpic acid ester double prodrugs.

Authors:  P Suhonen; T Järvinen; P Rytkönen; P Peura; A Urtti
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

6.  The effect of a modified beta-cyclodextrin, SBE4-beta-CD, on the aqueous stability and ocular absorption of pilocarpine.

Authors:  K Järvinen; T Järvinen; D O Thompson; V J Stella
Journal:  Curr Eye Res       Date:  1994-12       Impact factor: 2.424

7.  In vitro corneal permeability of diclofenac sodium in formulations containing cyclodextrins compared to the commercial product voltaren ophtha.

Authors:  O Reer; T K Bock; B W Müller
Journal:  J Pharm Sci       Date:  1994-09       Impact factor: 3.534

8.  Pilocarpine prodrugs. II. Synthesis, stability, bioconversion, and physicochemical properties of sequentially labile pilocarpine acid diesters.

Authors:  H Bundgaard; E Falch; C Larsen; G L Mosher; T J Mikkelson
Journal:  J Pharm Sci       Date:  1986-08       Impact factor: 3.534

9.  Sulfobutyl ether beta-cyclodextrin (SBE-beta-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits.

Authors:  T Järvinen; K Järvinen; A Urtti; D Thompson; V J Stella
Journal:  J Ocul Pharmacol Ther       Date:  1995       Impact factor: 2.671

  9 in total
  2 in total

1.  Intravenous formulation of N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine (HET0016) for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation.

Authors:  Ying Mu; Megan M Klamerus; Tricia M Miller; Lisa C Rohan; Steven H Graham; Samuel M Poloyac
Journal:  Drug Metab Dispos       Date:  2008-08-25       Impact factor: 3.922

2.  Cyclodextrin Derivative Enhances the Ophthalmic Delivery of Poorly Soluble Azithromycin.

Authors:  Anil Thakur; Sourabh Jain; Anjali Pant; Akanksha Sharma; Rajiv Kumar; Neha Singla; Ashish Suttee; Santosh Kumar; Ravi P Barnwal; Om Prakash Katare; Gurpal Singh
Journal:  ACS Omega       Date:  2022-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.